INTERNATIONAL PATENT: LEAL THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR MODULATING SPTLC2"

GENEVA, July 3 -- LEAL THERAPEUTICS, INC. (17 Briden StreetWorcester, MA 01605) filed a patent application (PCT/US2024/060495) for "COMPOSITIONS AND METHODS FOR MODULATING SPTLC2" on Dec 17, 2024. With publication no. WO/2025/136934, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABELIOVICH, Asa (1107 BroadwayApt 15aNew York, NY 10010), HECKMAN, Laura (2101 Market Street #1106Philadelphia, PA 19103), RHINN, Herve (141 Downey StreetSan Francisco, CA 94117)

Abstract: Aspects of the disclosure relate to compositions and ...